Ebola haemorrhagic fever - A review

Journal of Infection

Volumn 40, Issue 1, 2000, Pages 16-20

  Colebunders, R ^a   Borchert, M ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; EBOLA VIRUS; PREVALENCE; REVIEW; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION; ZOONOSIS;

EID: 0034060436     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.1999.0603     Document Type: Review

References (50)

1. Bull WHO. 56:1978;271-293.
2. Bull WHO. 56:1978;247-270.
3. Jezek Z., Szczeniowski M. Y., Muyembe T., McCormick J. B., Heymann D. L. Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 1981-1985. J Infect Dis. 179:1999;S60-S64.
4. Khan A. S., Tshioko Kweteminga F., Heymann D. L. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis. 179:1999;S76-S86.
5. Georges A-J., Leroy E. M., Renaut A. A. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis. 179:1999;S65-S75.
6. Georges-Courbot M. C., Sanchez A., Lu C. Y. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis. 3:1997;59-62.
7. Wkly Epidemiol Rec. 71:1996;359.
8. Jahrling P. B., Geisbert T. W., Dalgard D. W. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet. 335:1999;502-505.
9. Rollin P. E., Williams R. J., Bressler D. S. Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis. 179 (Suppl 1):1999;S108-S114.
10. Wkly Epidemiol Rec. 74:1999;157-158.
11. Peters C. J., Sanchez A., Feldmann H., Rollin P., Nichol S., Kzaizek T. G. Filoviruses as emerging pathogens. Semin Virol. 5:1994;147-154.
12. Sanchez A., Ksiazek T. G., Rollin P. E. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis. 179:1999;S164-S169.
13. Bwaka M. A., Bonnet M-J., Calain P. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo : clinical observations in 103 patients. J Infect Dis. 179:1999;S1-S7.
14. Ndambi R., Akamituna P., Bonnet M-J., Mazaya Tukadila A., Tamfum-Muyembe J-J., Colebunders R. Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis. 179:1999;S8-S10.
15. Sadek R. F., Khan A. S., Stevens G., Peters C. J., Ksiazek T. G. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995 : determinants of survival. J Infect Dis. 179:1999;S24-S27.
16. Muppa K., Masamba M. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis. 179:1999;S18-S23.
17. Kibadi K., Mupapa K., Kuvula K. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis. 179:1999;S13-S14.
18. Rowe A. K., Bertolli J., Khan A. S., Mukunu R. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis. 179:1999;S28-S35.
19. Le Guenno B., Formenty P., Boesch C. Ebola virus outbreaks in the Ivory Coast and Liberia, 1994-1995. Klenk H. D. Marburg and Ebola Viruses. 1999;77-84 Springer
20. Formenty P., Hatz C., Le Guenno B., Stoll A., Rogenmoser P., Widmer A. Human infection due to Ebola virus, subtype Ivory Coast : clinical and biologic presentation. J Infect Dis. 179:1999;S48-S53.
21. De Roo A., Ado B., Rose B., Guimard Y., Fonck K., Colebunders R. Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo : their feelings and experiences. Trop Med Int Health. 3:1998;883-885.
22. Ksiazek T. G., Rollin P. E., Williams A. J. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen and IgG and IgM antibody findings among EHF patients in Kikwit, 1995. J Infect Dis. 179:1999;S177-S187.
23. Guimard Y., Bwaka M. A., Colebunders R. The organization of the care for patients with Ebola haemorrhagic fever during the epidemic in Kikwit, Democratic Republic of Congo, 1995. J Infect Dis. 179:1999;S268-S273.
24. Ksiazek T. G., West C. P., Rollin P. E., Jahrling P. B., Peters C. J. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis. 179:1999;S192-S198.
25. Zaki S. R., Shieh W-J., Greer P. W. A novel immunohistochemical assay for detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J Infect Dis. 179:1999;S36-S47.
26. Lloyd E. S., Zaki S. R., Rollin P. E. Long-term disease survelliance in Bandundu Province, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever. J Infect Dis. 179:1999;S268-S273.
27. van der Groen G., Webb P. A., Wulff H., Lange J. Results of Ebola antibody surveys in various population groups. Pattyn S. R. Ebola Virus Haemorrhagic Fever. 1978;203-205 Elsevier/North-Holland Biomedical Press, Amsterdam.
28. Tomori O., Bertolli J., Rollin P. E. Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 179:1999;S98-S101.
29. Busico K. M., Marshall K. L., Ksiazek T. G. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis. 179:1999;S102-S107.
30. Zaki S. R., Goldsmith C. S. Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol. 235:1999;97-116.
31. Villinger F., Rollin P. E., Brar S. S. Markedly elevated levels of interferon (IFN)-g, IFN-a, interleukin (IL)-2, IL-10, and tumor necrosis factor-a associated with fatal Ebola virus infection. J Infect Dis. 179:1999;S188-S191.
32. Dowell S. F., Mukunu R., Ksiazek T. G. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo: 1995. J Infect Dis. 179:1999;S87-S91.
33. Muyembe-Tamfum J. J., Kipasa M., Kiyungu C., Colebunders R. Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis. 179:1999;S259-S262.
34. Johnson E., Jaax N., White J., Jahrling P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol. 76:1995;227-236.
35. Jaax N., Jahrling P., Geisbert T. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet. 346:1995;1669-1671.
36. Jahrling P. B., Geisbert T. W., Jaax N. K., Hanes M. A., Ksiazek T. G., Peters C. J. Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 US epizootic. Arch Virol Suppl. 11:1996;115-134.
37. Roels T. H., Bloom A. S., Buffington J. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis. 179:1999;S92-S97.
38. Rodriguez L. L., De Roo A., Guimard Y. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 179:1999;S170-S176.
39. Kudoyarova-Zubavichene N. M., Sergeyev N. N., Chepurnov A. A., Netesov S. V. Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. J Infect Dis. 179:1999;S218-223.
40. Jahrling P. B., Geisbert T. W., Geisbert J. B. Evaluation of immune globulin and recombinant interferon-a2b for treatment of experimental Ebola virus infections. J Infect Dis. 179:1999;S224-S234.
41. Huggins J., Zhang Z-X., Bray M. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model. J Infect Dis. 179:1999;S240-S247.
42. Ksiazek T. G., West C. P., Rollin P. E., Jahrling P. B., Peters C. J. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis. 179:1999;S192-S198.
43. Morb Mortal Wkly Rep. 39:1990;221.
44. Morb Mortal Wkly Rep. 39:1990;266-267, 273.
45. Gonzalez J. P., Josse R., Johnson E. D. Antibody prevalence against haemorrhagic fever viruses in randomized representative central African populations. Res Virol. 140:1989;319-331.
46. Breman J. G., Johnson K. M., van der Groen G. A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. J Infect Dis. 179:1999;S139-147.
47. Monath T. P. Ecology of Marburg and Ebola viruses: speculations and directions for future research. J Infect Dis. 179:1999;S127-S138.
48. Reiter P., Turell M., Coleman R. Field investigations of an outbreak of Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: arthropod studies. J Infect Dis. 179:1999;S148-S154.
49. Swanepoel R., Leman P. A., Burt F. J. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis. 2:1996;321-325.
50. Le Guenno B., Formenty P., Wyers M., Gounon P., Walker F., Boesch C. Isolation and partial characterization of a new strain of Ebola virus. Lancet. 1:1995;664-666.